Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-067242
Filing Date
2008-12-12
Accepted
2008-12-12 19:25:25
Documents
2
Period of Report
2008-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd226304.html 4  
1 FORM 4 rrd226304.xml 4 7108
2 rrd202661_228458.htm EX-24. 2389
  Complete submission text file 0001181431-08-067242.txt   11668
Mailing Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104
Business Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104 (415) 875-7880
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 7TH AVE 48TH FLOOR NEW YORK NY 10019
Business Address 787 7TH AVE 48TH FLOOR NEW YORK NY 10019 2125544284
Kazam Joshua A (Reporting) CIK: 0001221355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 081247996